跳至主要内容
临床试验/NCT04958980
NCT04958980Unknown不适用

The Effectiveness of the Multiprofessional Approach in an Educational Group in the Control of Diabetes Mellitus in Patients Using Oral Hypoglycemic Agents From a Basic Health Unit in the City of Guarulhos/ SP: a Randomized Study

Leonardo Paroche de Matos0 个研究点目标入组 24 人开始时间: 2021年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
24
主要终点
Comparison of glycemic control

研究概览

简要总结

OBJECTIVE: to verify the effectiveness of adopting the practice of educational groups in primary care and the multiprofessional role in the control of diabetes mellitus in adults. METHODOLOGY: a randomized clinical study carried out in an educational group at the Basic Health Unit Nova Bonsucesso with six monthly meetings scheduled with 24 patients with type II diabetes mellitus users of oral hypoglycemic agents divided into two subgroups: 12 users in the control group and 12 users in the control group. study (which will receive the interventions of the multidisciplinary team) and will be accompanied by laboratory tests and individual evaluations to verify the effectiveness of the multidisciplinary action in the control of diabetes mellitus.

详细描述

INTRODUCTION

diabetes mellitus is highlighted as an obstacle in health equipment because it is a chronic disease and has a high mortality rate. The pathology results in hyperglycemia, disorders or insufficiency of several organs. OBJECTIVE: to verify the effectiveness of adopting the practice of educational groups in primary care and the multidisciplinary role in the control of diabetes mellitus in adults. THEORETICAL BACKGROUND: type II diabetes mellitus (type II DM) is a pathology that represents a high risk for cardiovascular, renal, ophthalmological complications and in several other systems. It is considered a major issue to be controlled by health services, as the high cost of treatments related to the sequelae of type II DM, as well as high rates of hospitalizations and associated therapies have been increasing and decompensating public budgets. Primary care has a fundamental role in preventing the disease and associated complications. METHODOLOGY: randomized clinical study conducted in an educational group at the Basic Health Unit Nova Bonsucesso with six monthly meetings scheduled with 24 patients with type II diabetes mellitus users of oral hypoglycemic agents divided into two subgroups: 12 users in the control group and 12 users in the group study (which will receive the interventions of the multidisciplinary team) and will be accompanied by laboratory tests and individual evaluations to verify the effectiveness of the multidisciplinary performance in the control of diabetes mellitus. RESULTS: the participants are expected to show improvements in the control of the pathology and awareness about the relevance of self-care, facts that will be observed through laboratory data and subsequent multi-professional evaluations.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

盲法说明

The formation of randomized groups will occur by random drawing, obeying the proportion of 1: 1 in both groups, that is, 12 participants in each group (control and intervention) that will be selected after the screening carried out by the research nurse (to verify some possible exclusion criteria for research participants), reducing the occurrence of methodological bias in the sampling phase and ensuring the possibility that all participants can be included in the intervention group.

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •24 on-insulin-dependent type II diabetes patients (users of oral hypoglycemic agents),
  • •over 18 years of age,
  • •both sexes,
  • •with no restrictions on physical exercise (found after medical evaluation)
  • •who agreed to participate voluntarily in the study (after signature of the Free and Informed Consent Form)
  • •of a specific area of the Family Health Strategy - chosen by the proximity to the Basic Health Unit.

排除标准

  • •Patients with associated pathologies: cardiovascular conditions: Congestive Heart Failure,Decompensated Systemic Arterial Hypertension, Sequela of Acute Myocardial Infarction
  • •Cancer patients,
  • •Respiratory conditions: Chronic Obstructive Pulmonary Disease, Severe asthma and any other disabling lung condition.
  • •Endocrine conditions that aggravate diabetes mellitus: Pancreatic pathologies (pancreatitis, pancreatic cysts, obstructions and pancreatic cancer)
  • •Patients with impaired vision,
  • •Motor or balance disorders,
  • •With any special needs (physical or intellectual),
  • •With consequences resulting from the evolution of type II diabetes mellitus
  • •Users who refused to participate in the research.

研究组 & 干预措施

Placebo

No Intervention

The control group will be evaluated in 2 stages: at the beginning and at the end of the study and will be accompanied only with scheduled medical consultations (also simulating the reality of basic health units with a traditional model of care) and the intervention group will undergo evaluations with the multiprofessional team on two occasions (at the beginning and at the end of the study)

Specific and educational guidelines on pathology care (diabetes mellitus)

Active Comparator

Multiprofessional educational guidelines and analysis of the following exams:

  • Periodontal record, bleeding rate on and visible plaque;
  • Body mass index (BMI): weight (kg) divided by height squared (m²);
  • Serum glucose values;
  • Glycated hemoglobin;
  • Blood count: hemoglobin;
  • Urea: male:
  • Creatinine male;
  • Uric acid;
  • Oxalacetic glutamic transaminase;
  • Glutamic pyruvic transaminase;
  • Total cholesterol and fractions: Cholesterol, Non HDL, LDL, VLDL;
  • Triglycerides;
  • Type I urine;
  • Vitamin D3 25OH;
  • Microalbuminuria;
  • Blood pressure: systolic;
  • Abdominal circumference.

干预措施: Specific and educational guidelines on care for pathology (diabetes mellitus) according to each profession involved in the research (Behavioral)

结局指标

主要结局

Comparison of glycemic control

时间窗: 6 months

Serum glucose values: 80 to 130mg/ dl

% of participants at risk for worsening diabetes mellitus

时间窗: 6 months

Glycated hemoglobin: \<7%

Concentration of participants at risk for developing kidney complications [urea]

时间窗: 6 months

Urea: male: \<40mg/ dl, female: \<55mg/ dl

Concentration of participants at risk of developing kidney failure

时间窗: 6 months

Creatinine male: 0.7-1.30mg/ dl, female: 0.5- 1.10mg/ dl

Concentration of participants at risk of developing systemic arterial hypertension associated with diabetes mellitus

时间窗: 6 months

Blood pressure: systolic- \<130mmHg, diastolic: \<85mHg

incidence of periodontitis associated with diabetes mellitus

时间窗: 6 months

Periodontal record: up to 3mm.

Risk rate for periodontal disease (in %) associated with diabetes mellitus

时间窗: 6 months

Bleeding rate on and visible plaque: up to 10%;

Association of glycemic control with changes in body weight (in kg)

时间窗: 6 months

Body mass index (BMI): weight (kg) divided by height squared (m²);

Concentration of participants at risk for the development of liver complications

时间窗: 6 months

Oxalacetic glutamic transaminase: male: \<50U/ L, female: \<40U/ L

% of participants at risk for anemic diseases

时间窗: 6 months

Blood count: hemoglobin: male 13-17g/ dl, female: 12 -15g/ dl

Concentration of participants at risk for the development of kidney stones and worsening of diabetes mellitus

时间窗: 6 months

Uric acid: male: 3.4- 7.0mg/ dl, female: 2.4- 7.4mg/ dl

Concentration of participants with renal complications and urinary glucose and protein elimination associated with diabetes mellitus

时间窗: 6 months

Type I urine: negative proteinuria and glycosuria

Concentration of participants at increased risk for diabetes complications related to vitamin D deficiency

时间窗: 6 months

Vitamin D3 25OH: \<60y: \>20ng/ dl, \>60y: \>30ng/dl

Observation of the risk of developing nephropathies, retinopathies and cardiovascular diseases associated with diabetes mellitus

时间窗: 6 months

Microalbuminuria: \<30mg/day

Concentration of participants at increased risk for diabetes complications related to increased waist circumference

时间窗: 6 months

Abdominal circumference: male: 102cm, female: 88cm

Concentration of participants at risk for the development of liver failure associated with diabetes mellitus

时间窗: 6 months

Glutamic pyruvic transaminase: male: \<50U/ L, female: \<40U/ L

Observation of triglyceride rates and the development of risk for cardiovascular complications associated with diabetes mellitus

时间窗: 6 months

Triglycerides: \<175mg/ dl

Observation of the risk of developing cardiovascular diseases associated with diabetes mellitus

时间窗: 6 months

Total cholesterol and fractions: Cholesterol: 190mg/ dl, HDL:\> 40mg/ dl, Non HDL: \<160mg/ dl, LDL: \<100mg/ dl, VLDL: 10- 50mg/ dl

次要结局

未报告次要终点

研究者

发起方
Leonardo Paroche de Matos
申办方类型
Other
责任方
Principal Investigator
主要研究者

Leonardo Paroche de Matos

main researcher

Leonardo Paroche de Matos

相似试验